CARG/Semaglutide is a composite peptide extensively studied for its combined potential effects on cellular pathways and metabolic regulation. This 5MG/5MG formulation is specifically designed for laboratory research in controlled experimental settings, offering researchers the opportunity to explore its properties and interactions.

The individual components of this product have been rigorously lab-tested to ensure quality and purity. The peptides are blended after separate testing, ensuring consistency and reliability for in vitro applications.

<strong>Note:</strong> This product is not intended for human or animal use.